Enliven Therapeutics, Inc. ($ELVN)
Filing Information
| Accession Number | 0001967163-26-000001 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 13, 2026 |
| Document Date | Jan 9, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
48,300
Total Value
$1,351,762.20
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHIEF OPERATING OFFICER | Common Stock | โ | Jan 9, 2026 | Sale | 48,057 | $27.98 | $1,344,836.70 | 215,254 | Indirect | See footnote | View Details | |
CHIEF OPERATING OFFICER | Common Stock | โ | Jan 9, 2026 | Sale | 243 | $28.50 | $6,925.50 | 215,011 | Indirect | See footnote | View Details |